Merck KGaA snags rights to 30 BMS meds; Shire taps Bacardi exec as new CFO

Merck KGaA bought the rights to distribute 30 of Bristol-Myers Squibb's prescription drugs in Argentina, Chile and five other Latin American countries for an undisclosed price. Report

Shire named Graham Hetherington as its new CFO and director as of July 1; Hetherington, formerly CFO of Bacardi, will replace Angus Russell, who's taking over as CEO of the U.K.-based drugmaker. Release

Allergan has inked a deal to buy QLT's Aczone gel 5 percent product, a topical treatment for acne vulgaris, for $150 million. Report

Perrigo filed an abbreviated new drug application with the FDA to market a generic version of Medicis Pharmaceuticals' Vanos cream; Medicis already has filed suit to keep the copy off the market. Report

When asked which company stood out at last week's ASCO conference in Chicago, oncologists cited Genentech at the top of the list, according to a survey by oncology data specialist AlphaDetail. Release

Express Scripts is selling its infusion pharmacy business to a subsidiary of Walgreen for an undisclosed amount, the pharmacy benefit manager announced Tuesday. Report

The RPM Report focuses on a new effort to revise and improve the way the FDA approves proposed proprietary drug names. Report

The University of Miami medical school says that a new, 1.4 million square foot laboratory complex will help propel development of a new biotech cluster in the region. Report

Researchers are unveiling positive data at the American Diabetes Association's meeting for new DPP-4 inhibitors for diabetes. Report

CytRx has inked a deal to buy Innovive Pharmaceuticals, adding its four experimental oncology therapies to its pipeline. Report

And Finally... Medical researchers are homing in on a wonder drug that may significantly reduce the risk of heart disease, cancer, diabetes and many other diseases--sunshine. Report